Pfenex (PFNX) Reports Development & License Agreement with NT Pharma Group for PF708 Therapeutic Equivalent Candidate to Forteo
Tweet Send to a Friend
Pfenex Inc. (NYSE: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (1011) today announced an agreement under ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
